Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32745179.
- Also identified by DOI 10.1093/cid/ciaa1086 and PMC identifier 8204786.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with autoantibodies to interferon-γ (IFN-γ) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-γ who had progressive infection, resulting in clinical and radiographic improvement.
Medical subject headings
- Mycobacterium Infections, Nontuberculous
- Nontuberculous Mycobacteria